- Blumberg E, Robbins SN, Adimora A, et al. Persistent fever in association with infective
endocarditis. Clin Infect Dis 1992; 15:980–996. - Sexton DJ, Spelman D. Current best practices and guidelines: assessment and management of
complications in infective endocarditis. In: Durack DT, ed. Infectious Disease Clinics of North
America. Vo. 16. Philadelphia: WB Saunders Company, 2002:507–521. - Wilson W, Giuliani E, Danielson G, et al. Management of complications of infective endocarditis.
Mayo Clin Proc 1982; 57:162–169. - Martinez-Selles M, Munoz P, Estevez A, et al. Long-term outcome of infective endocarditis in non-
intravenous drug users. Mayo Clin Proc 2008; 83:1213–1217. - Karchmer AW. Infective endocarditis. In: Zips DP, Libby P, Bonow RO, et al, eds. Braunwald’s
Heart Disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia:Elseiver Saunders, 2005:
1633–1658. - Weinstein L. Brusch JL. Medical management. In: Weinstein L, Brusch JL, eds. Infective
Endocarditis New York:Oxford University Press, 1996:256–304. - Welton DE, Young JB, Gentry WO, et al. Recurrent infective endocarditis: analysis of predisposing
factors and clinical features. Am J Med 1979; 66:932–939. - Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily
dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995;
21:1406–1410. - Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, and a micrometer
therapy and management of complications. A statement for health-care professionals from the
Rheumatic Fever, Endocarditis and Kawasaki Disease, Council of Cardiovascular Disease in the
Young and the Councils on Clinical Cardiology, Stroke and Cardiovascular Surgery and
Anesthesia, American Heart Association-executive summary. Circulation 2005; 111:e394–e434. - Brusch JL, Larsen CT. Medical management. In: Brusch JL, ed. Infective endocarditis, Management
in the Era of Intravascular Devices. New York: Informa Health Care, 2007:273–312.
222a. Buckholtz K, Larsen CT, et al. Severity of gentamicin’s nephrotoxic effect on patients with infective
endocarditis: a prospective observation of cohort study of 373 patients. Clin Infect Dis 2009; 48:65–71. - Hoen B. Special issues on the management of infective endocarditis caused by Gram-positive cocci.
Infect Dis Clin North Am 2002; 16:437–452. - Tuohy MJ, Procop GW, Washington J. Antimicrobial susceptibility of Abiotrophia adiacens and
Abiotrophia defectiva. Diagn Microbiol Infect Dis 2000; 38:189–191. - Pulliam L, Inokuchi S, Hadley WK, et al. Penicillin tolerance in experimental streptococcal
endocarditis. Lancet 1979; 2:957–961. - Eliopoulos GM. Antibiotic resistance in enterococcus species: an update. In: Remington J, Schwarz
M, eds. Current Clinical Topics in Infectious Diseases. Cambridge, Mass: Blackwell Scientific,
1996:21–51. - Eliopoulos GM. Aminoglycoside resistant enterococcal endocarditis. Med Clin North Am 1993;
17:117–172. - Fantin B, Carbon C. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin
combination for treatment of enterococcus faecalis-induced experimental endocarditis. Antimicrob
Agents Chemother 1990; 34:2387–2391. - Wilson WR, Karchmer AW, Dsajani AS, et al. Antibiotic treatment of adults with infective
endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA
1995; 274: 1705–1714. - Thompson RL, Lavin B, Talbot GH. Endocarditis due to vancomycin-resistant enterococcus faecium
in an immunocompromised patients: cure by administering combination therapy with Quinpristin/
dalfopristin and high dose ampicillin. South Med J 2003; 96:818–820. - Eliopoulos GM, Thavin- Eliopoulos C, Moellering RC Jr. Contribution of animal models in the
search for effective therapy for endocarditis due to enterococci with high-level resistance to
gentamicin. Clin Infect Dis 1992; 15:58–62. - DeRyke CA, Sutherland C, Zhang B, et al. Serum bactericidal activities of high-dose streptomycin
with and without coadministration of gentamicin against isolates of Staphylococcus aureus and
Enterococcus species. Antimicrob Agents Chemother 2006; 50:3529–3544. - Gavalda J, Len O, Moro J, et al. Brief communication: treatment of Enterococcus faecalis
endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007; 146:574–579. - Karchmer AW. Staphylococcus aureus and vancomycin: the sequel. Ann Inten Med 1991; 115:
739–741. - Nannini EC, Singh KV, Murray BE. Relapse of type A beta-lactamase-producing Staphylococcus
aureus native valve endocarditis cefazolin therapy: Revisiting the issue. Clin Infect Dis 2003;
37:1194–1198.
Infective Endocarditis and Its Mimics in Critical Care 257